Last updated on March 2017


Brief description of study


Detailed Study Description

A study to assess the efficacy and safety of PT010 relative to PT003 and PT009 on COPD exacerbations over a 52 week treatment period in subjects with moderate to very severe COPD. Phase III

Clinical Study Identifier: TX148177

Find a site near you

Start Over